Raymond James & Associates’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$30.6K Hold
38,825
﹤0.01% 3855
2024
Q2
$36.8K Buy
+38,825
New +$36.8K ﹤0.01% 3782